China · Delayed Price · Currency is CNY Bright Eye Hospital Group Statistics
Total Valuation
SHE:301239 has a market cap or net worth of CNY 6.54 billion. The enterprise value is 8.07 billion.
| Market Cap | 6.54B |
| Enterprise Value | 8.07B |
Important Dates
The last earnings date was Tuesday, April 28, 2026.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:301239 has 148.86 million shares outstanding. The number of shares has decreased by -0.63% in one year.
| Current Share Class | 148.86M |
| Shares Outstanding | 148.86M |
| Shares Change (YoY) | -0.63% |
| Shares Change (QoQ) | +1.23% |
| Owned by Insiders (%) | 44.09% |
| Owned by Institutions (%) | 26.84% |
| Float | 70.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 87.88 |
| PS Ratio | 2.27 |
| PB Ratio | 3.04 |
| P/TBV Ratio | 4.35 |
| P/FCF Ratio | 20.33 |
| P/OCF Ratio | 12.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.35, with an EV/FCF ratio of 25.09.
| EV / Earnings | -459.78 |
| EV / Sales | 2.89 |
| EV / EBITDA | 17.35 |
| EV / EBIT | 59.35 |
| EV / FCF | 25.09 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.95.
| Current Ratio | 1.16 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.95 |
| Debt / EBITDA | 3.98 |
| Debt / FCF | 6.35 |
| Interest Coverage | 9.24 |
Financial Efficiency
Return on equity (ROE) is -0.44% and return on invested capital (ROIC) is -0.92%.
| Return on Equity (ROE) | -0.44% |
| Return on Assets (ROA) | 2.36% |
| Return on Invested Capital (ROIC) | -0.92% |
| Return on Capital Employed (ROCE) | 4.64% |
| Weighted Average Cost of Capital (WACC) | 6.43% |
| Revenue Per Employee | 561,485 |
| Profits Per Employee | -3,428 |
| Employee Count | 5,121 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 8.63 |
Taxes
In the past 12 months, SHE:301239 has paid 62.64 million in taxes.
| Income Tax | 62.64M |
| Effective Tax Rate | 117.87% |
Stock Price Statistics
The stock price has increased by +0.99% in the last 52 weeks. The beta is 0.77, so SHE:301239's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +0.99% |
| 50-Day Moving Average | 36.90 |
| 200-Day Moving Average | 36.98 |
| Relative Strength Index (RSI) | 63.26 |
| Average Volume (20 Days) | 4,182,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301239 had revenue of CNY 2.88 billion and -17.56 million in losses. Loss per share was -0.12.
| Revenue | 2.88B |
| Gross Profit | 1.18B |
| Operating Income | 178.51M |
| Pretax Income | 53.14M |
| Net Income | -17.56M |
| EBITDA | 325.98M |
| EBIT | 178.51M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 571.72 million in cash and 2.04 billion in debt, with a net cash position of -1.47 billion or -9.88 per share.
| Cash & Cash Equivalents | 571.72M |
| Total Debt | 2.04B |
| Net Cash | -1.47B |
| Net Cash Per Share | -9.88 |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 14.05 |
| Working Capital | 145.54M |
Cash Flow
In the last 12 months, operating cash flow was 527.67 million and capital expenditures -205.88 million, giving a free cash flow of 321.79 million.
| Operating Cash Flow | 527.67M |
| Capital Expenditures | -205.88M |
| Depreciation & Amortization | 153.37M |
| Net Borrowing | 75.00M |
| Free Cash Flow | 321.79M |
| FCF Per Share | 2.16 |
Margins
Gross margin is 41.17%, with operating and profit margins of 6.21% and -0.61%.
| Gross Margin | 41.17% |
| Operating Margin | 6.21% |
| Pretax Margin | 1.85% |
| Profit Margin | -0.61% |
| EBITDA Margin | 11.34% |
| EBIT Margin | 6.21% |
| FCF Margin | 11.19% |
Dividends & Yields
SHE:301239 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.63% |
| Shareholder Yield | 0.63% |
| Earnings Yield | -0.27% |
| FCF Yield | 4.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |